|
1
|
Monge CC: Chronic mountain sickness.
Physiol Rev. 23:166–184. 1943.
|
|
2
|
León-Velarde F, Maggiorini M, Reeves JT,
et al: Consensus statement on chronic and subacute high altitude
diseases. High Alt Med Biol. 6:147–157. 2005.PubMed/NCBI
|
|
3
|
Penaloza D and Arias-Stella J: The heart
and pulmonary circulation at high altitudes: healthy highlanders
and chronic mountain sickness. Circulation. 115:1132–1146. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gao Y: High Altitude Military Medicine.
Chongqing Publishing House; Chongqing: 2005
|
|
5
|
Wood S, Norboo T, Lilly M, Yoneda K and
Eldridge M: Cardiopulmonary function in high altitude residents of
Ladakh. High Alt Med Biol. 4:445–454. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu TY: Chronic mountain sickness on the
Qinghai-Tibetan plateau. Chin Med J (Engl). 118:161–168.
2005.PubMed/NCBI
|
|
7
|
Monge CC, Arrequi A and León-Velarde F:
Pathophysiology and epidemiology of chronic mountain sickness. Int
J Sports Med. 13(Suppl 1): S79–S81. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Beall CM, Brittenham GM, Macuaga F and
Barragan M: Variation in hemoglobin concentration among samples of
high-altitude natives in the Andes and the Himalayas. Am J Hum
Biol. 2:639–651. 1990. View Article : Google Scholar
|
|
9
|
Wu T, Wang X, Wei C, et al: Hemoglobin
levels in Qinghai-Tibet: different effects of gender for Tibetans
vs. Han J Appl Physiol. 98:598–604. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kryger M, McCullough RE, Collins D,
Scoggin CH, Weil JV and Grover RF: Treatment of excessive
polycythemia of high altitude with respiratory stimulant drugs. Am
Rev Respir Dis. 117:455–464. 1978.PubMed/NCBI
|
|
11
|
Vargas M, Leon-Velarde F, Monge CC, Orozco
E and Rey L: Enalapril in the treatment of chronic mountain
sickness. Wilderness Environ Med. 7:193–194. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Plata R, Cornejo A, Arratia C, et al;
Commission on Global Advancement of Nephrology (COMGAN), Research
Subcommittee of the International Society of Nephrology.
Angiotensin-converting-enzyme inhibition therapy in altitude
polycythaemia: a prospective randomised trial. Lancet. 359:663–666.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pelouch V, Kolár F, Ost'ádal B, Milerová
M, Cihák R and Widimský J: Regression of chronic hypoxia-induced
pulmonary hypertension, right ventricular hypertrophy, and
fibrosis: effect of enalapril. Cardiovasc Drugs Ther. 11:177–185.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Richalet JP, Rivera-Ch M, Maignan M, et
al: Acetazolamide for Monge's disease: efficiency and tolerance of
6-month treatment. Am J Respir Crit Care Med. 177:1370–1376.
2008.PubMed/NCBI
|
|
15
|
Li P, Huang J, Tian HJ, Huang QY, Jiang CH
and Gao YQ: Regulation of bone marrow hematopoietic stem cell is
involved in high-altitude erythrocytosis. Exp Hematol. 39:37–46.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gonzales GF, Gasco M, Tapia V and
Gonzales-Castañeda C: High serum testosterone levels are associated
with excessive erythrocytosis of chronic mountain sickness in men.
Am J Physiol Endocrinol Metab. 296:E1319–E1325. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gonzales GF, Tapia V, Gasco M, Rubio J and
Gonzales-Castañeda C: High serum zinc and serum testosterone levels
were associated with excessive erythrocytosis in men at high
altitudes. Endocrine. 40:472–480. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bailey DM, Dehnert C, Luks AM, et al:
High-altitude pulmonary hypertension is associated with a free
radical-mediated reduction in pulmonary nitric oxide
bioavailability. J Physiol. 588:4837–4847. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liggins J, Bluck LJ, Runswick S, Atkinson
C, Coward WA and Bingham SA: Daidzein and genistein content of
fruits and nuts. J Nutr Biochem. 11:326–331. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gencel VB, Benjamin MM, Bahou SN and
Khalil RA: Vascular effects of phytoestrogens and alternative
menopausal hormone therapy in cardiovascular disease. Mini Rev Med
Chem. 12:149–174. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hall WL, Formanuik NL, Harnpanich D, et
al: A meal enriched with soy isoflavones increases nitric
oxide-mediated vasodilation in healthy postmenopausal women. J
Nutr. 138:1288–1292. 2008.PubMed/NCBI
|
|
22
|
Kim H, Lee MJ, Kim JE, Park SD, Moon HI
and Park WH: Genistein suppresses tumor necrosis
factor-alpha-induced proliferation via the apoptotic signaling
pathway in human aortic smooth muscle cells. J Agric Food Chem.
58:2015–2019. 2010. View Article : Google Scholar
|
|
23
|
Vera R, Galisteo M, Villar IC, et al: Soy
isoflavones improve endothelial function in spontaneously
hypertensive rats in an estrogen-independent manner: role of
nitric-oxide synthase, superoxide, and cyclooxygenase metabolites.
J Pharmacol Exp Ther. 314:1300–1309. 2005. View Article : Google Scholar
|
|
24
|
Li X, Gao Z, Liu F, Xiang D, Jiang C and
Huang Q: The preventive effects of phytoestrogen on chronic hypoxic
pulmonary hypertension in rats. Chinese Pharm Bull. 20:897–900.
2004.(In Chinese).
|
|
25
|
Li X, Gao Z, Liu F, Jiang C, Xiang D and
Huang Q: The effects of genistein on pulmonary vascular structural
remodeling induced by chronic hypoxia. Chinese Pharml Bull.
20:1257–1261. 2004.(In Chinese).
|
|
26
|
Li X, Gao Y, Liu F, et al: The regulative
effects of genistein on vascular active factors in chronic hypoxic
rats. Food Sci. 20(10): 219–223. 2005.(In Chinese).
|
|
27
|
Allemann Y, Sartori C, Lepori M, et al:
Echocardiographic and invasive measurements of pulmonary artery
pressure correlate closely at high altitude. Am J Physiol Heart
Circ Physiol. 279:H2013–H2016. 2000.PubMed/NCBI
|
|
28
|
Hamilton-Reeves JM, Vazquez G, Duval SJ,
Phipps WR, Kurzer MS and Messina MJ: Clinical studies show no
effects of soy protein or isoflavones on reproductive hormones in
men: results of a meta-analysis. Fertil Steril. 94:997–1007. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Scherrer U, Vollenweider L, Delabays A, et
al: Inhaled nitric oxide for high-altitude pulmonary edema. N Engl
J Med. 334:624–629. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoit BD, Dalton ND, Erzurum SC, Laskowski
D, Strohl KP and Beall CM: Nitric oxide and cardiopulmonary
hemodynamics in Tibetan highlanders. J Appl Physiol. 99:1796–1801.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ge RL, Mo VY, Januzzi JL, et al: B-type
natriuretic peptide, vascular endothelial growth factor,
endothelin-1, and nitric oxide synthase in chronic mountain
sickness. Am J Physiol Heart Circ Physiol. 300:H1427–1433. 2011.
View Article : Google Scholar : PubMed/NCBI
|
